Release Date: 13/07/16 15:15 Summary: Half Yearly Report and Accounts-ILH.AX Price Sensitive: No Download Document 1.71MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%